Wei Lin
Chief Tech/Sci/R&D Officer bij REVOLUTION MEDICINES, INC.
Vermogen: 3 M $ op 31-03-2024
Actieve functies van Wei Lin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| 2SEVENTY BIO, INC. | Director/Board Member | 07-03-2023 | - |
| Independent Dir/Board Member | 07-03-2023 | - | |
| REVOLUTION MEDICINES, INC. | Chief Tech/Sci/R&D Officer | 01-04-2023 | - |
Loopbaan van Wei Lin
Eerdere bekende functies van Wei Lin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ERASCA, INC. | Chief Tech/Sci/R&D Officer | 01-01-2021 | 10-04-2023 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 14-11-2018 | 05-01-2021 |
| Roche (China) Co. Ltd. | Corporate Officer/Principal | 01-01-2006 | 01-01-2009 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Opleiding van Wei Lin
| Haverford College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
| China | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| ERASCA, INC. | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Roche (China) Co. Ltd. |
